Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Biomarker & Hepatocellular Carcinoma (HCC)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Combining multi-OMICSwith radiomics represents apromising strategy for evaluating tumor heterogenicity and for identifying biomarkers of response and prognosis.
Casadei-Gardini et al. 2020 Expert Review of Anticancer Therapy 20: 63-74

There are additional biomarkers that merit further exploration in hepatobiliary cancers including FGF19, ERRFI1, TERT, BAP1, BRAF, CDKN2A, tumor mutational burden and ERBB2 (HER2/neu).
DeLeon et al. 2018…

References (Sources)

Developments in predictive biomarkers for hepatocellular carcinoma therapy
Casadei-Gardini et al. 2020 Expert Review of Anticancer Therapy 20: 63-74
Review
Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma
DeLeon et al. 2018
Review
Progress and prospects of biomarkers in primary liver cancer
Gao et al. 2020b Int J Oncol 57: 54-66
Review

AI Chat

5/29/2026

Chat with our artificial intelligence:

Start chat!

Biomarker & Hepatocellular Carcinoma (HCC)

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat